Skip to main content
Top

Endocrine

Issue 1/2003

Content (9 Articles)

Regulation of ghrelin secretion and action

Jesus P. Camiña, Marcos C. Carreira, Dragan Micic, Manuel Pombo, Fahrettin Kelestimur, Carlos Dieguez, Felipe F. Casanueva

Targeting the ghrelin receptor

Romano Deghenghi, Fabio Broglio, Mauro Papotti, Giampiero Muccioli, Ezio Ghigo

Ghrelin and the endocrine pancreas

Fabio Broglio, Cristina Gottero, Andrea Benso, Flavia Prodam, Marco Volante, Silvia Destefanis, Carlotta Gauna, Giampiero Muccioli, Mauro Papotti, Aart Jan van der Lely, Ezio Ghigo

Growth hormone-releasing hormone and growth hormone secretagogues in normal aging

George R. Merriam, Robert S. Schwartz, Michael V. Vitiello

Neuropeptide Y

Staya P. Kalra, Pushpa S. Kalra

Fibromyalgia

Marjorie L. Shuer

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine